Oral Lichen Planus

Oral and Maxillofacial Surgery Clinics of North America

Volumn 25, Issue 1, 2013, Pages 93-100

  Au, Justin ^a   Patel, Dhaval ^a   Campbell, John H ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Autoimmune disease; Erosive; Lichen planus; Oral; Reticular

Indexed keywords

CELL TRANSFORMATION; CLASSIFICATION; HUMAN; LICHEN PLANUS; PATHOLOGY; PRECANCER; REVIEW;

CELL TRANSFORMATION, NEOPLASTIC; HUMANS; LICHEN PLANUS, ORAL; PRECANCEROUS CONDITIONS;

EID: 84873490413     PISSN: 10423699     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coms.2012.11.007     Document Type: Review

References (66)

1. Altman J., Perry H.O. The variations and course of lichen planus. Arch Dermatol 1961, 84:179-191.
2. DeRossi S.S., Ciarrocca K.N. Lichen planus, lichenoid drug reactions, and lichenoid mucositis. Dent Clin North Am 2005, 49(1):77-89. viii.
3. Giunta J.L. Oral lichenoid reactions versus lichen planus. J Mass Dent Soc 2001, 50(2):22-25.
4. Nakamura S., Hiroki A., Shinohara M., et al. Oral involvement in chronic graft-versus-host disease after allogeneic bone marrow transplantation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996, 82(5):556-563.
5. Eckardt A., Starke O., Stadler M., et al. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus. Oral Oncol 2004, 40(8):811-814.
6. Hasseus B., Jontell M., Brune M., et al. Langerhans cells and T cells in oral graft versus host disease and oral lichen planus. Scand J Immunol 2001, 54(5):516-524.
7. Carrozzo M., Francia Di Celle P., Gandolfo S., et al. Increased frequency of HLA-DR6 allele in Italian patients with hepatitis C virus-associated oral lichen planus. Br J Dermatol 2001, 144(4):803-808.
8. Carrozzo M., Uboldi de Capei M., Dametto E., et al. Tumor necrosis factor-alpha and interferon-gamma polymorphisms contribute to susceptibility to oral lichen planus. J Invest Dermatol 2004, 122(1):87-94.
9. Mattila R., Rautava J., Syrjanen S. Human papillomavirus in oral atrophic lichen planus lesions. Oral Oncol 2012, 48(10):980-984.
10. Lodi G., Giuliani M., Majorana A., et al. Lichen planus and hepatitis C virus: a multicentre study of patients with oral lesions and a systematic review. Br J Dermatol 2004, 151(6):1172-1181.
11. Jaafari-Ashkavandi Z., Mardani M., Pardis S., et al. Oral mucocutaneous diseases: clinicopathologic analysis and malignant transformation. J Craniofac Surg 2011, 22(3):949-951.
12. Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol 2002, 46(2):207-214.
13. Scully C., el-Kom M. Lichen planus: review and update on pathogenesis. J Oral Pathol 1985, 14(6):431-458.
14. van der Meij E.H., Schepman KP., Smeele L.E., et al. A review of the recent literature regarding malignant transformation of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999, 88(3):307-310.
15. Eisenberg E. Oral lichen planus: a benign lesion. J Oral Maxillofac Surg 2000, 58(11):1278-1285.
16. Silverman S. Oral lichen planus: a potentially premalignant lesion. J Oral Maxillofac Surg 2000, 58(11):1286-1288.
17. Lodi G., Scully C., Carrozzo M., et al. Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. Clinical management and malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005, 100(2):164-178.
18. Pindborg J.J., Wahi P.N. Histological typing of cancer and precancer of the oral mucosa. International histological classification of tumours 1997, 87. Springer, Berlin. 2nd edition.
19. Rhodus N.L., Myers S., Kaimal S. Diagnosis and management of oral lichen planus. Northwest Dent 2003, 82(2):17-19. 22-5.
20. Farhi D., Dupin N. Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clin Dermatol 2010, 28(1):100-108.
21. Kawamura E., Nakamura S., Sasaki M., et al. Accumulation of oligoclonal T cells in the infiltrating lymphocytes in oral lichen planus. J Oral Pathol Med 2003, 32(5):282-289.
22. Yamamoto T., Nakane T., Osaki T. The mechanism of mononuclear cell infiltration in oral lichen planus: the role of cytokines released from keratinocytes. J Clin Immunol 2000, 20(4):294-305.
23. Iijima W., Ohtani H., Nakayama T., et al. Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism. Am J Pathol 2003, 163(1):261-268.
24. Scully C., Beyli M., Ferreiro M.C., et al. Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med 1998, 9(1):86-122.
25. Sugerman P.B., Savage N.W., Walsh L.J., et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002, 13(4):350-365.
26. Ismail S.B., Kumar S.K., Zain R.B. Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation. J Oral Sci 2007, 49(2):89-106.
27. Lodi G., Scully C., Carrozzo M., et al. Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005, 100(1):40-51.
28. Jungell P., Konttinen Y.T., Nortamo P., et al. Immunoelectron microscopic study of distribution of T cell subsets in oral lichen planus. Scand J Dent Res 1989, 97(4):361-367.
29. Sugerman P.B., Savage N.W., Zhou X., et al. Oral lichen planus. Clin Dermatol 2000, 18(5):533-539.
30. Mattila R., Syrjanen S. Caspase cascade pathways in apoptosis of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010, 110(5):618-623.
31. Chainani-Wu N., Silverman S., Lozada-Nur F., et al. Oral lichen planus: patient profile, disease progression and treatment responses. J Am Dent Assoc 2001, 132(7):901-909.
32. Zhao Z.Z., Sugerman PB., Zhou X.J., et al. Mast cell degranulation and the role of T cell RANTES in oral lichen planus. Oral Dis 2001, 7(4):246-251.
33. Zhou X.J., Sugerman P.B., Savage N.W., et al. Matrix metalloproteinases and their inhibitors in oral lichen planus. J Cutan Pathol 2001, 28(2):72-82.
34. Lukac J., Brozović S., Vucicević-Boras V., et al. Serum autoantibodies to desmogleins 1 and 3 in patients with oral lichen planus. Croat Med J 2006, 47(1):53-58.
35. Sugerman P.B., Satterwhite K., Bigby M. Autocytotoxic T-cell clones in lichen planus. Br J Dermatol 2000, 142(3):449-456.
36. Muller S. Oral manifestations of dermatologic disease: a focus on lichenoid lesions. Head Neck Pathol 2011, 5(1):36-40.
37. Schlosser B.J. Lichen planus and lichenoid reactions of the oral mucosa. Dermatol Ther 2010, 23(3):251-267.
38. Shklar G. Lichen planus as an oral ulcerative disease. Oral Surg Oral Med Oral Pathol 1972, 33(3):376-388.
39. Jungell P., Konttinen Y.T., Malmstrom M. Basement membrane changes in oral lichen planus. Proc Finn Dent Soc 1989, 85(2):119-124.
40. Haapalainen T., Oksala O., Kallioinen M., et al. Destruction of the epithelial anchoring system in lichen planus. J Invest Dermatol 1995, 105(1):100-103.
41. van der Meij E.H., van der Waal I. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med 2003, 32(9):507-512.
42. Kramer I.R., Lucas R.B., Pindborg J.J., et al. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978, 46(4):518-539.
43. Cheng S., Kirtschig G., Cooper S., et al. Interventions for erosive lichen planus affecting mucosal sites. Cochrane Database Syst Rev 2012, (2). CD008092.
44. Carbone M., Goss E., Carrozzo M., et al. Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up. J Oral Pathol Med 2003, 32(6):323-329.
45. Vincent S.D., Fotos P.G., Baker K.A., et al. Oral lichen planus: the clinical, historical, and therapeutic features of 100 cases. Oral Surg Oral Med Oral Pathol 1990, 70(2):165-171.
46. Silverman S., Gorsky M., Lozada-Nur F., et al. A prospective study of findings and management in 214 patients with oral lichen planus. Oral Surg Oral Med Oral Pathol 1991, 72(6):665-670.
47. Thongprasom K., Chaimusig M., Korkij W., et al. A randomized-controlled trial to compare topical cyclosporin with triamcinolone acetonide for the treatment of oral lichen planus. J Oral Pathol Med 2007, 36(3):142-146.
48. Ungphaiboon S., Nittayananta W., Vuddhakul V., et al. Formulation and efficacy of triamcinolone acetonide mouthwash for treating oral lichen planus. Am J Health Syst Pharm 2005, 62(5):485-491.
49. Zegarelli E.V., Kutscher A.H., Mehrhof A. Long-lasting lozenges with triamcinolone acetonide. Treatment of erosive lichen planus of oral mucosa. N Y State J Med 1969, 69(18):2463-2464.
50. Cawson R.A. Treatment of oral lichen planus with betamethasone. Br Med J 1968, 1(5584):86-89.
51. Lehner T., Lyne C. Adrenal function during topical oral corticosteroid treatment. Br Med J 1969, 4(5676):138-141.
52. Malhotra A.K., Khaitan BK., Sethuraman G., et al. Betamethasone oral mini-pulse therapy compared with topical triamcinolone acetonide (0.1%) paste in oral lichen planus: a randomized comparative study. J Am Acad Dermatol 2008, 58(4):596-602.
53. Xia J., Li C., Hong Y., et al. Short-term clinical evaluation of intralesional triamcinolone acetonide injection for ulcerative oral lichen planus. J Oral Pathol Med 2006, 35(6):327-331.
54. Krogh P., Holmstrup P., Thorn J.J., et al. Yeast species and biotypes associated with oral leukoplakia and lichen planus. Oral Surg Oral Med Oral Pathol 1987, 63(1):48-54.
55. Dreyer W.P. The clinical manifestations of oral lichen planus. J Dent Assoc S Afr 1983, 38(10):619-624.
56. Carbone M., Conrotto D., Carrozzo M., et al. Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide. Oral Dis 1999, 5:44-49.
57. Scully C., Eisen D., Carrozzo M. Management of oral lichen planus. Am J Clin Dermatol 2000, 1(5):287-306.
58. Levell N.J., MacLeod R.I., Marks J.M. Lack of effect of cyclosporin mouthwash in oral lichen planus. Lancet 1991, 337(8744):796-797.
59. Frances C., Boisnic S., Etienne S., et al. Effect of the local application of ciclosporine A on chronic erosive lichen planus of the oral cavity. Dermatologica 1988, 177(3):194-195.
60. Gorouhi F., Solhpour A., Beitollahi J.M., et al. Randomized trial of pimecrolimus cream versus triamcinolone acetonide paste in the treatment of oral lichen planus. J Am Acad Dermatol 2007, 57(5):806-813.
61. Morrison L., Kratochvil F.J., Gorman A. An open trial of topical tacrolimus for erosive oral lichen planus. J Am Acad Dermatol 2002, 47(4):617-620.
62. Laeijendecker R., Tank B., Dekker S.K., et al. A comparison of treatment of oral lichen planus with topical tacrolimus and triamcinolone acetonide ointment. Acta Derm Venereol 2006, 86(3):227-229.
63. Rozycki T.W., Rogers R.S., Pittelkow M.R., et al. Topical tacrolimus in the treatment of symptomatic oral lichen planus: a series of 13 patients. J Am Acad Dermatol 2002, 46(1):27-34.
64. Vente C., Reich K., Rupprecht R., et al. Erosive mucosal lichen planus: response to topical treatment with tacrolimus. Br J Dermatol 1999, 140(2):338-342.
65. Kaliakatsou F., Hodgson T.A., Lewsey J.D., et al. Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol 2002, 46(1):35-41.
66. Mansourian A., Momen-Heravi F., Saheb-Jamee M., et al. Comparison of aloe vera mouthwash with triamcinolone acetonide 0.1% on oral lichen planus: a randomized double-blinded clinical trial. Am J Med Sci 2011, 342(6):447-451.